Sandbox ID Upper Respiratory Tract: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) |
Gerald Chi- (talk | contribs) |
||
| Line 19: | Line 19: | ||
===Parapharyngeal space infection=== | ===Parapharyngeal space infection=== | ||
::* '''Parapharyngeal space infection'''<ref>{{cite book | last = Flint | first = Paul | title = Cummings otolaryngology head & neck surgery | publisher = Mosby/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 978-0323052832 }}</ref><ref>{{Cite journal| doi = 10.1016/j.otc.2008.01.002| issn = 0030-6665| volume = 41| issue = 3| pages = 459–483, vii| last1 = Vieira| first1 = Francisco| last2 = Allen| first2 = Shawn M.| last3 = Stocks| first3 = Rose Mary S.| last4 = Thompson| first4 = Jerome W.| title = Deep neck infection| journal = Otolaryngologic Clinics of North America| date = 2008-06| pmid = 18435993}}</ref> | |||
:::* Causative pathogens | |||
::::* Viridans and other streptococci | |||
::::* Staphylococcus | |||
::::* Peptostreptococcus | |||
::::* Bacteroides | |||
::::* Other oral anaerobes | |||
:::* Preferred regimen (immunocompetent host): ([[Penicillin G]] 2–4 MU IV q4–6h {{and}} [[Metronidazole]] 0.5 g IV q6h) {{or}} [[Ampicillin-Sulbactam]] 2 g IV q4h {{or}} [[Clindamycin]] 600 mg IV q6h | |||
:::* Preferred regimen (immunocomppromised host): [[Cefotaxime]] 2 g IV q6h {{or}} [[Ceftizoxime]] 4 g IV q8h {{or}} [[Piperacillin]] 3 g IV q4h {{or}} Imipenem 500 mg IV q6h {{or}} [[Imipenem]] 500 mg IV q6h {{or}} [[Gatifloxacin]] 400 mg IV q24h | |||
===Pharyngitis, diphtheria=== | ===Pharyngitis, diphtheria=== | ||
Revision as of 06:54, 11 June 2015
Epiglottitis
Jugular vein phlebitis
Laryngitis
Lemierre's syndrome
Ludwig's angina
- Causative pathogens
- Viridans and other streptococci
- Peptostreptococcus
- Bacteroides
- Other oral anaerobes
- Preferred regimen (immunocompetent host): (Penicillin G 2–4 MU IV q4–6h AND Tobramycin 2 mg/kg IV q8h) OR Ampicillin-Sulbactam 2 g IV q4h OR Clindamycin 600 mg IV q6h OR Doxycycline 200 mg IV q12h OR Cefoxitin 2 g IV q6h OR Cefotetan 2 g IV q12h
- Preferred regimen (immunocomppromised host): Cefotaxime 2 g IV q6h OR Ceftizoxime 4 g IV q8h OR Piperacillin 3 g IV q4h OR Imipenem 500 mg IV q6h OR Meropenem 1 g IV q8h OR Gatifloxacin 200 mg IV q24h
Parapharyngeal space infection
-
- Causative pathogens
- Viridans and other streptococci
- Staphylococcus
- Peptostreptococcus
- Bacteroides
- Other oral anaerobes
- Preferred regimen (immunocompetent host): (Penicillin G 2–4 MU IV q4–6h AND Metronidazole 0.5 g IV q6h) OR Ampicillin-Sulbactam 2 g IV q4h OR Clindamycin 600 mg IV q6h
- Preferred regimen (immunocomppromised host): Cefotaxime 2 g IV q6h OR Ceftizoxime 4 g IV q8h OR Piperacillin 3 g IV q4h OR Imipenem 500 mg IV q6h OR Imipenem 500 mg IV q6h OR Gatifloxacin 400 mg IV q24h
-
Pharyngitis, diphtheria
Pharyngitis, streptococcal
Sinusitis, Acute
Sinusitis, Chronic
Sinusitis, Post-intubation
Sinusitis, Treatment failure
Stomatitis
Stomatitis, aphthous
Stomatitis, herpetic
Submandibular space infection
Tonsillitis
Ulcerative gingivitis
Vincent's angina
- ↑ Flint, Paul (2010). Cummings otolaryngology head & neck surgery. Philadelphia, PA: Mosby/Elsevier. ISBN 978-0323052832.
- ↑ Vieira, Francisco; Allen, Shawn M.; Stocks, Rose Mary S.; Thompson, Jerome W. (2008-06). "Deep neck infection". Otolaryngologic Clinics of North America. 41 (3): 459–483, vii. doi:10.1016/j.otc.2008.01.002. ISSN 0030-6665. PMID 18435993. Check date values in:
|date=(help) - ↑ Flint, Paul (2010). Cummings otolaryngology head & neck surgery. Philadelphia, PA: Mosby/Elsevier. ISBN 978-0323052832.
- ↑ Vieira, Francisco; Allen, Shawn M.; Stocks, Rose Mary S.; Thompson, Jerome W. (2008-06). "Deep neck infection". Otolaryngologic Clinics of North America. 41 (3): 459–483, vii. doi:10.1016/j.otc.2008.01.002. ISSN 0030-6665. PMID 18435993. Check date values in:
|date=(help)